Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-25-012327
Filing Date
2025-07-01
Accepted
2025-07-01 16:48:42
Documents
1
Period of Report
2025-06-27

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 3298
  Complete submission text file 0001062993-25-012327.txt   4920
Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE #210 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE #210 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Issuer) CIK: 0001860871 (see all company filings)

EIN.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O TEVOGEN BIO HOLDINGS INC. 15 INDEPENDENCE BOULEVARD WARREN NJ 07059
Business Address
Desai Kirti (Reporting) CIK: 0002011765 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41002 | Film No.: 251097097